66 related articles for article (PubMed ID: 7655406)
1. Studies on immunomodulatory properties of isoniazid. Influence of isoniazid on responsiveness of peripheral blood mononuclear cells to interleukin-2.
Kucharz EJ
Cent Eur J Public Health; 1995 May; 3(2):65-6. PubMed ID: 7655406
[TBL] [Abstract][Full Text] [Related]
2. Studies on immunomodulatory properties of isoniazid. II. Effect of isoniazid on interleukin 2 production and interleukin 2-receptor expression.
Kucharz EJ; Sierakowski SJ
J Hyg Epidemiol Microbiol Immunol; 1990; 34(2):207-11. PubMed ID: 2212642
[TBL] [Abstract][Full Text] [Related]
3. Studies on immunomodulatory properties of isoniazid. I. Effect of isoniazid on mitogen- and anti-CD3 antibody-induced proliferation of human peripheral blood mononuclear cells and T cells.
Kucharz EJ; Sierakowski SJ
J Hyg Epidemiol Microbiol Immunol; 1990; 34(1):99-105. PubMed ID: 2141035
[TBL] [Abstract][Full Text] [Related]
4. Studies on immunomodulatory properties of isoniazid. III. Effect of isoniazid on proliferation of interleukin-dependent and interleukin-independent cell line.
Kucharz EJ; Sierakowski SJ
J Hyg Epidemiol Microbiol Immunol; 1990; 34(3):305-8. PubMed ID: 2273247
[TBL] [Abstract][Full Text] [Related]
5. Isoprinosine potentiation of human peripheral blood mononuclear cell response to mitogens: kinetics and effect on expression of the IL-2 receptor and the activity of interleukin 2.
Lomnitzer R
J Clin Lab Immunol; 1988 Oct; 27(2):91-6. PubMed ID: 2469797
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 2 and mitogen driven proliferation in human peripheral mononuclear cells: a kinetic analysis.
Ferrero E; Manfredi A; Bianchi E; Schönheit A; Sabbadini MG; Rugarli C
Haematologica; 1989; 74(4):355-8. PubMed ID: 2507408
[TBL] [Abstract][Full Text] [Related]
7. Differential quantitative effects of interleukin (IL)-2 and IL-15 on cytotoxic activity and proliferation by lymphocytes from patients receiving in vivo IL-2 therapy.
de Jong JL; Farner NL; Javorsky BR; Lindstrom MJ; Hank JA; Sondel PM
Clin Cancer Res; 1998 May; 4(5):1287-96. PubMed ID: 9607589
[TBL] [Abstract][Full Text] [Related]
8. Studies on immunomodulatory properties of isoniazid: V. Influence of isoniazid on secretion of interleukin-1.
Kucharz EJ; Sierakowski SJ
J Hyg Epidemiol Microbiol Immunol; 1992; 36(1):119-22. PubMed ID: 1619288
[TBL] [Abstract][Full Text] [Related]
9. Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).
Hank JA; Surfus JE; Gan J; Jaeger P; Gillies SD; Reisfeld RA; Sondel PM
Clin Cancer Res; 1996 Dec; 2(12):1951-9. PubMed ID: 9816154
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome.
Hirano T; Akashi T; Keira T; Oka K; Ihoya N; Yoshida M
Clin Pharmacol Ther; 2000 Nov; 68(5):532-40. PubMed ID: 11103756
[TBL] [Abstract][Full Text] [Related]
11. The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells.
Lacaille F; Paradis K
Hepatology; 1993 Jul; 18(1):165-72. PubMed ID: 8325607
[TBL] [Abstract][Full Text] [Related]
12. Effects of benzo[a]pyrene on concanavalin A-stimulated human peripheral blood mononuclear cells in vitro: inhibition of proliferation but no effect on parameters related to the G1 phase of the cell cycle.
Mudzinski SP
Toxicol Appl Pharmacol; 1993 Apr; 119(2):166-74. PubMed ID: 8097600
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
[TBL] [Abstract][Full Text] [Related]
14. In vitro immunomodulatory properties of tucaresol in HIV infection.
Clerici M; Cogliati M; Rizzardini G; Colombo F; Fossati S; Rhodes J; Bray D; Piconi S
Clin Immunol; 2000 Dec; 97(3):211-20. PubMed ID: 11112360
[TBL] [Abstract][Full Text] [Related]
15. Effect of luteinizing hormone alpha-subunit on IL-2 and sIL-2R in vitro secretions from human peripheral blood mononuclear cells.
Komorowski J; Gradowski G; Stepień H
Cytobios; 1997; 89(356):31-7. PubMed ID: 9297814
[TBL] [Abstract][Full Text] [Related]
16. Suppressive efficacy of roxithromycin against human peripheral-blood mononuclear cells stimulated with hemolytic streptococci superantigen.
Kamogawa S; Kagami K; Maeda M; Arai K; Okubo Y; Tsuboi R; Hirano T
Eur J Pharmacol; 2009 Jan; 602(2-3):439-47. PubMed ID: 19068210
[TBL] [Abstract][Full Text] [Related]
17. Effect of interleukin-2 on synthesis of B cell activating factor belonging to the tumor necrosis factor family (BAFF) in human peripheral blood mononuclear cells.
Suzuki K; Setoyama Y; Yoshimoto K; Tsuzaka K; Abe T; Takeuchi T
Cytokine; 2008 Oct; 44(1):44-8. PubMed ID: 18707897
[TBL] [Abstract][Full Text] [Related]
18. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.
Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J
Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406
[TBL] [Abstract][Full Text] [Related]
19. Effect of the growth hormone-releasing hormone [GHRH(1-44)NH2] on IL-6 and IL-8 secretion from human peripheral blood mononuclear cells in vitro.
Siejka A; Stepien T; Lawnicka H; Krupinski R; Komorowski J; Stepien H
Endocr Regul; 2005 Jan; 39(1):7-11. PubMed ID: 16107133
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell differentiation in a peripheral blood. Mononucleated cell culture treated with interleukin-2.
Capelli E; Nano R; Barni S
Haematologica; 1997; 82(5):634. PubMed ID: 9407738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
